Published in

Elsevier, The Lancet, 10249(396), p. 467-478, 2020

DOI: 10.1016/s0140-6736(20)31604-4

Links

Tools

Export citation

Search in Google Scholar

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Journal article published in 2020 by Pedro M. Folegatti ORCID, Katie J. Ewer, Parvinder K. Aley, Brian Angus, Stephan Becker, Sandra Belij-Rammerstorfer, Duncan Bellamy ORCID, Sagida Bibi, Elizabeth A. Clutterbuck, Mustapha Bittaye, Saul N. Faust, Christina Dold ORCID, Amy L. Flaxman ORCID, Bassam Hallis, Adam Finn and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO